|
|
|
|
|
16.02.26 - 08:48
|
Why 25 February is critical for Diageo Shares (Fool)
|
|
|
Zaven Boyrazian explains why Diageo shares could be getting ready for a massive multi-year rally following the firm's highly anticipated earnings update.
The post Why 25 February is critical for Diageo Shares appeared first on The Motley Fool UK....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.02.26 - 08:12
|
BT shares: here are the latest growth and dividend forecasts! (Fool)
|
|
|
BT shares have leapt by a third over the last year. But can the FTSE 100 stock continue surging? Royston Wild considers the company's investment case.
The post BT shares: here are the latest growth and dividend forecasts! appeared first on The Motley Fool UK....
|
|
|
16.02.26 - 08:12
|
£5,000 invested in Greggs shares 5 years ago is now worth… (Fool)
|
|
|
After five years of ups and downs, Mark Hartley calculates just how much £5k in Greggs' shares would be worth today. Is the stock still a FTSE gem?
The post £5,000 invested in Greggs shares 5 years ago is now worth… appeared first on The Motley Fool UK....
|
|
|
|
|
|
|
16.02.26 - 08:06
|
Director Dealing (Cision)
|
|
|
16 February 2026
4basebio PLC
("4basebio" or the "Company")
Director Dealing
Cambridge, UK, 16 February 2026 – 4basebio PLC (AIM: 4BB), an innovation driven biotechnology company enabling and accelerating development of advanced therapy medicinal products (ATMPs) through its high performant GMP-grade synthetic DNA products, announces that on 13 February 2026 it was informed that Dr. Amy Walker, Chief Executive Officer of the Company made the following purchase in ordinary shares in the capital of the Company through the market.
Further details are set out in the Notification...
|
|
|
|
|
|